Order one of our free resource packs today! Fill out the form here.
Download our pilot report, which presents the work of community-based FibroScan screening in the Isle of Wight community drug and alcohol treatment service to assess feasibility, impact and benefits as a health promotion tool for individuals at low to moderate risk of alcohol- related liver disease.
Download our pilot report, which presents our work that tested a targeted social media-based awareness and engagement approach aimed at reaching people who have previously used drugs but are no longer engaged with drug treatment services.
Download this hepatitis C information leaflet, translated into Welsh, created in collaboration with Public Health Wales.
Download our best-practice case study, which documents the conception, implementation, development, and impact of a joint Liver and Alcohol Clinic delivered through collaboration between Path to Recovery (P2R) and East London NHS Foundation Trust (ELFT)) and Bedford Hospital hepatology services.
Download our latest impact report, which covers our national work from April 2025 to March 2026.
Download our National Cepheid GeneXpert Report.
Read our report that explores the survey results looking at the distribution and use of Cepheid GeneXpert machines for hepatitis C diagnostics, data recording processes, governance considerations, and interoperability challenges.
Download our case study exploring the essential pillars of good quality needle and syringe provision.
Download our FibroScan Census, a census we completed with NHS England to understand the current use of FibroScans within Hepatitis C Operational Delivery Networks (ODNs) and community drug treatment services (DTS) across England.
Download our case study from Inclusion Staffordshire (STaRS) on Improving Pharmacy Needle and Syringe Provision.
Download this case study on Inclusion One Recovery Bucks peer to peer Naloxone project.
Download our top tips for engaging people in hepatitis C testing
